A pan-cancer analysis of the oncogenic role of ERCC6L

BACKGROUND: Excision repair cross-complementation group 6 like (ERCC6L), a polo-like kinase 1 (PLK1)-interacting checkpoint helicase, confers a high risk of cancer and enhances the progression of a variety of cancers. The present investigation aimed to elucidate the pan-cancer expression patterns of...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Zhimin, Fei, Lihong, Hou, Guoxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773625/
https://www.ncbi.nlm.nih.gov/pubmed/36550435
http://dx.doi.org/10.1186/s12885-022-10452-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773625/
https://www.ncbi.nlm.nih.gov/pubmed/36550435
http://dx.doi.org/10.1186/s12885-022-10452-3

Ejemplares similares